← Open Payments lookup

JENNIFER DALTON: Open Payments

NPI 1104323062 · LUDINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$895 in 41 payments from 15 companies in 2025. Trend: 2023 $450 · 2024 $480 · 2025 $895

Food & beverage: $895
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$224
Otsuka America Pharmaceutical, Inc.6$155
Neurocrine BioSciences, Inc.4$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Indivior Inc.2$44
Supernus Pharmaceuticals, Inc.2$43
Teva Pharmaceuticals USA, Inc.2$40
ABBVIE INC.2$39
Vanda Pharmaceuticals Inc.2$38
Orexo US, Inc.2$38

Products named: COBENFY, INGREZZA, CAPLYTA, REXULTI, ABILIFY MAINTENA, SUBLOCADE, Qelbree, VRAYLAR.

Industry payments across MI — which companies pay providers there.